DLHAX Holdings Information

DLHAX is a mutual fund with a total of 108 individual holdings. The top holdings are Pfizer stock at 4.41%, UCB SA at 4.18%, AbbVie at 4.12%, Merck & Co. at 4.08%, and Gilead Sciences at 3.95%.

Total Holdings

108

Top 10 Percentage

38.37%

Asset Class

Equity

Fund Category

Health

Assets

752.37M

Forward PE Ratio

n/a

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	PFE	Pfizer Inc.	4.41%	1,207,000
2	EBR: UCB	UCB SA	4.18%	130,137
3	ABBV	AbbVie Inc.	4.12%	125,000
4	MRK	Merck & Co., Inc.	4.08%	215,000
5	GILD	Gilead Sciences, Inc.	3.95%	210,000
6	REGN	Regeneron Pharmaceuticals, Inc.	3.90%	38,000
7	LLY	Eli Lilly and Company	3.86%	26,000
8	UNH	UnitedHealth Group Incorporated	3.50%	70,000
9	EPA: SAN	Sanofi	3.21%	280,000
10	ELV	Elevance Health, Inc.	3.18%	63,000
11	SWX: ROP	Roche Holding AG	3.08%	55,000
12	HALO	Halozyme Therapeutics, Inc.	3.01%	220,000
13	LON: AZN	AstraZeneca PLC	2.72%	131,243
14	AMGN	Amgen Inc.	2.59%	47,000
15	TYO: 4519	Chugai Pharmaceutical Co., Ltd.	2.50%	450,000
16	VTRS	Viatris Inc.	2.48%	1,170,018
17	ILMN	Illumina, Inc.	2.47%	90,000
18	ORKA	Oruka Therapeutics, Inc.	2.26%	190,000
19	VRTX	Vertex Pharmaceuticals Incorporated	1.75%	25,000
20	ZBH	Zimmer Biomet Holdings, Inc.	1.65%	128,700
21	ALKS	Alkermes plc	1.57%	260,000
22	BSX	Boston Scientific Corporation	1.55%	250,000
23	ROIV	Roivant Sciences Ltd.	1.50%	338,181
24	MDT	Medtronic plc	1.45%	125,000
25	RCUS	Arcus Biosciences, Inc.	1.43%	379,100

Showing 25 of 108 holdings

Subscribe to see the full list

Activate Now

As of Aug 31, 2026